Quick Listen: Scrip's Five Must-Know Things

 
• By Ian Haydock

In this week's podcast version of Five Must-Know Things: a US setback for UCB; Lilly challenges Novo’s GLP franchise; Seagen searches for CEO after scandal; Hengrui hopes for US PD-1 success; and a look ahead at ASCO.

Scrip Five Must Know Things
weekly audio roundup of selected global biopharma insights

More from Business

More from Scrip